Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment.
- DOI
- 10.1016/j.ajpc.2026.101643
- Published
- 2026-04-17
- Container
- Am J Prev Cardiol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ajpc.2026.101643,
title = {Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment.},
author = {Schwartz GG and Szarek M and Cobbaert CM and Ruhaak LR and Schwertfeger M and Bhatt DL and Bittner VA and Goodman SG and Harrington RA and Stevanovic I and Tavori H and Reijnders E and Romijn F and van Neer NJM and White HD and Jukema JW and Steg PG.},
year = {2026},
journal = {Am J Prev Cardiol},
doi = {10.1016/j.ajpc.2026.101643},
url = {https://doi.org/10.1016/j.ajpc.2026.101643}
}RIS
TY - JOUR TI - Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment. AU - Schwartz GG AU - Szarek M AU - Cobbaert CM AU - Ruhaak LR AU - Schwertfeger M AU - Bhatt DL AU - Bittner VA AU - Goodman SG AU - Harrington RA AU - Stevanovic I AU - Tavori H AU - Reijnders E AU - Romijn F AU - van Neer NJM AU - White HD AU - Jukema JW AU - Steg PG. PY - 2026 JO - Am J Prev Cardiol DO - 10.1016/j.ajpc.2026.101643 UR - https://doi.org/10.1016/j.ajpc.2026.101643 ER -
APA
GG, S., M, S., CM, C., LR, R., M, S., DL, B., VA, B., SG, G., RA, H., I, S., H, T., E, R., F, R., NJM, V. N., HD, W., JW, J., & PG., S. (2026). Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment.. Am J Prev Cardiol. https://doi.org/10.1016/j.ajpc.2026.101643
Source records
- europe-pmc · retrieved 2026-09-25T04:46:50.742Z